Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$0.39
EPS est.
$0.35
EPS surprise
+11.43%
1-day move
+3.42%
Concentra Group Holdings reported better-than-expected earnings per share, which likely contributed to the positive stock reaction of 3.42%. However, the lack of revenue information and management commentary leaves some uncertainty about the company's overall performance. Investors may be encouraged by the EPS beat, but the absence of guidance could lead to cautious sentiment moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | $0.34 | +11.43% |
| Revenue | — | $553M | — |
No transcript is on record, and the analysis is based on numerical results only.
Concentra Group Holdings Parent, Inc. operates in the health care sector, focusing on health care facilities. As a player in this industry, it is important for investors to monitor its performance, especially as health care demand continues to evolve post-pandemic.
Last quarter
In Q4-2025, Concentra reported an EPS of $0.27, beating expectations by 20%. The stock saw a slight increase of 1.07% the following day.
EPS beat streak
4Q
EPS beat rate
88%
Avg EPS surprise
+8.34%
Avg 1-day reaction
+0.03%
Analysts expect Concentra to report solid earnings this quarter, with a consensus EPS of $0.34. Investors will be watching closely for any surprises in revenue and profitability.
Bull case
If Concentra beats the EPS estimate, it could indicate strong operational efficiency and demand for its services, potentially leading to a positive stock reaction.
Bear case
Conversely, if the company misses expectations, it may raise concerns about its growth trajectory and market position, leading to a negative reaction.
Key metrics to watch
EPS
$0.34Earnings per share is a key indicator of profitability and helps gauge the company's financial health.
Revenue
$553MTotal revenue reflects the company's ability to generate sales and is crucial for assessing growth.
The print will turn on these.
Q1
Will EPS exceed $0.34?
A beat on EPS could signal strong operational performance and investor confidence, impacting stock price positively.
Q2
What is the revenue outlook for the upcoming quarters?
Revenue growth is critical for assessing the company's market position and future profitability, which will heavily influence investor sentiment.
—
Est. EPS
$1.91
Est. Rev
$7292.1B
Impl. Move
±6.0%
Why consensus could be wrong
The consensus may underestimate Concentra's ability to leverage its existing facilities for increased patient volume, especially as health care demand stabilizes.
Supporting evidence
The company has consistently beaten EPS estimates in recent quarters, indicating stronger operational performance than anticipated.
Options pricing suggests a significant move, which may reflect investor uncertainty rather than a clear bearish outlook.
Key risk
If revenue growth significantly outpaces expectations, it could invalidate the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it will reflect the company's ability to navigate post-pandemic challenges and capitalize on market opportunities.
Bull confirmed if
An EPS of $0.36 or higher, coupled with revenue exceeding $558M, would confirm the bull case.
Bear confirmed if
An EPS below $0.32 or revenue below $544M would confirm the bear case.
What the market is pricing for the move.
Implied Move
±7.98%
Historical Avg
±1.6%
The options market is pricing in a significant move around the earnings announcement, suggesting heightened investor uncertainty.
Options are pricing ±8.0% while CON has averaged ±1.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
24.5%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: X of Y (Z%)
This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 6.3%, with a raw directional average of -0.2% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
90.62%
of float
Insider
9.65%
of float
Holders
405
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
17,753,714 sh · $646.2M
13.92%
4.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Concentra beats expectations, history suggests a potential stock increase of around 1.65%, confirming strong demand and operational efficiency.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline of approximately 1.30% based on historical patterns, raising concerns about growth prospects.
The lines on the call that would change the story.
Price (T.Rowe) Associates Inc
17,715,257 sh · $644.8M
13.89%
4.0%
Vanguard Portfolio Management LLC
6,817,456 sh · $248.2M
5.35%
1.2%
Vanguard Capital Management LLC
5,129,815 sh · $186.7M
4.02%
0.7%
State Street Corporation
4,840,099 sh · $176.2M
3.80%
5.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.